- Global Pharma News & Resources

Cholera Vaccines (Dukoral, Shanchol, Vaxchora) Market Size, Share & Trends Analysis Report 2018 - Global Forecast to 2025 -

The "Cholera Vaccines Market Size, Share & Trends Analysis Report By Product (Dukoral, Shanchol, Vaxchora), By Region (North America, APAC, Europe, MEA, Latin America), And Segment Forecasts, 2018 - 2025" report has been added to's offering.

The global cholera vaccines market size is expected to reach USD 117.1 million by 2025, exhibiting a CAGR of 8.2% during the forecast period. Increase in number of initiatives and rising awareness about cholera are major factors contributing toward market growth.

Governments in regions affected by cholera are striving to eliminate the disease by developing a strong public health and sanitation infrastructure. In February 2013, the Government of Haiti launched a 10-year National Cholera Elimination Plan. The United Nations Organization has made elimination of cholera a key UN priority and offers support to the Haitian Government by establishing a mechanism to respond to an alert within 48 hours, household visits, and sensitization campaigns.

Furthermore, various research projects and studies, such as epidemiological and anthropological studies, are being conducted in Africa. Ongoing studies include using rapid diagnostics tests to detect Vibrio cholerae in samples of water to understand epidemic diffusion mechanisms and anticipate outbreaks. The Cholera Platform is working with the Global Task Force for Cholera Control (GTFCC) WASH working group. This association aims to develop a method for conducting case studies to control and prevent the disease.

Some of the key players are Valneva SE; Shantha Biotechnics Private Limited; and PaxVax, Inc.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Methodology and Scope

Chapter 3 Cholera Vaccines Market Variables, Trends & Scope

Chapter 4 Cholera Vaccines Market: Product Estimates & Trend Analysis

Chapter 5 Cholera Vaccines Market: Regional Estimates & Trend Analysis

Chapter 6 Competitive Landscape

  • Shantha Biotechnics Private Limited
  • Valneva SE
  • PaxVax, Inc.
  • Astellas Pharma, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc (GSK)
  • Pfizer, Inc.
  • Takeda Pharmaceutical Co., Ltd.
  • Emergent BioSolutions, Inc.
  • AstraZeneca
  • Mitsubishi Tanabe Pharma Corporation

For more information about this report visit

View source version on

Editor Details

Last Updated: 07-Nov-2018